A Phase I/II, Prospective, Single-centre, Open-label Study to Assess the Safety, feasibility and Efficacy of Activation of Localized Chemotherapy by Encapsulated Cell Therapy in Patients with Inoperable Pancreatic Carcinoma
Phase of Trial: Phase I/II
Latest Information Update: 05 Nov 2010
At a glance
- Drugs Microencapsulated P450 expressing cells Bavarian Nordic (Primary) ; Ifosfamide
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 05 Nov 2010 New trial record.